Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732348) titled 'Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist for Ovarian Stimulation in IVF/ICSI' on July 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)
Condition:
Infertility, Female
Ovulation Induction
Intervention:
Drug: Linzagolix
Drug: Ganirelix
Cetrorelix
Drug: Medroxyprogesterone Acetate
Dienogest
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enroll...